Peggy Lin is a senior health economics and outcomes research (HEOR) professional with 20 years of experience specializing in oncology and hematology. Currently serving as the Health Economics and Value Assessment Oncology Global Lead at Sanofi, Peggy has developed and executed HEOR and real-world evidence strategies, designed observational studies, and led health technology assessment submissions. Previously, they held positions at Outcome Sciences Inc., Shire, Analysis Group, QualityMetric Incorporated, and JWRG Inc., contributing to significant product launches and research initiatives. Peggy is pursuing a PhD in Sociology at the University of Massachusetts Amherst, driven by a passion for enhancing patient outcomes through impactful value strategies for innovative therapies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices